Dr. Martin Reese is Co-Founder, CEO, and President at Fabric Genomics (formerly Omicia). He is a pioneer in the field of genomics and bioinformatics, and has led and co-founded various companies such as ValiGen and Neomorphic. He co-created the two machine-learning algorithms VAAST and Phevor, which are key components of Fabric Genomics’ software platform and an essential part of the bioinformatics pipelines at institutions such as Rady Children’s Institute for Genomics, Genomics England, and LabCorp. Dr. Reese speaks all over the world about algorithms for genomics, machine-learning, AI, deep phenotyping, genomic medicine, and precision medicine. He holds a Master’s Degree in Medical Informatics from the University of Heidelberg and a Ph.D. in Genetics, jointly from the University of Hohenheim and The University of California, Berkeley.
Stephen Kingsmore, Rady Children’s Institute for Genomic Medicine
Kate Kernan, UPMC
The rapid development of genomic sequencing technologies has decreased the cost of genetic analysis to the extent that it seems plausible that genome-scale sequencing could have widespread availability in pediatric care. Genomic sequencing provides a powerful diagnostic modality for patients who manifest symptoms of monogenic disease and an opportunity to detect health conditions before their development. However, many technical, clinical, ethical, and societal challenges should be addressed before such technology is widely deployed in pediatric practice.